易通讯集团(08031)附属拟1500万港元出售约6.8%的VAX全部已发行股本

智通财经

Dec 30, 2024

智通财经APP讯，易通讯集团(08031)发布公告，卖方(ETS Investments Limited，公司的间接全资附属公司)与买方A(精益集团有限公司)于2024年12月30日(联交所交易时段后)订立买卖协议A，卖方有条件同意出售而买方A有条件同意购入待售股份A(92267股VAX股份，即VAX全部已发行股本约3.8%)，总代价为840万港元。

卖方与买方B(梁德辉)于2024年12月30日(联交所交易时段后)订立买卖协议B，卖方有条件同意出售而买方B有条件同意购入待售股份B(73118股VAX股份，即VAX全部已发行股本约3.0%)，总代价为660万港元。

董事局相信该等出售事项将使集团能够套现于VAX集团的投资。再者，考虑到(i)总代价相当于独立估值师所估算的16.54万股VAX股份的公平值1450万港元;(ii)卖方于2021年4月30日订立相关认购协议时16.54万股VAX股份的原认购价1290万港元;及(iii)预期来自该等出售事项的收益，该等出售事项诚属以有利价格套现16.54万股VAX股份的价值并将资源更好地分配至集团现有业务发展的大好良机。经考虑上述，董事相信该等出售事项的条款(包括总代价)乃按一般商业条款订立，诚属公平合理，且该等出售事项符合公司及股东的整体利益。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2495526651"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2495526651\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2495526651?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2024-12-30 23:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2495526651","market":"us","top_or_hot":-1,"title":"易通讯集团(08031)附属拟1500万港元出售约6.8%的VAX全部已发行股本","media":"智通财经","content":"<html><body><p>智通财经APP讯，<a href=\"https://laohu8.com/S/08031\">易通讯集团</a>(08031)发布公告，卖方(ETS Investments Limited，公司的间接全资附属公司)与买方A(精益集团有限公司)于2024年12月30日(联交所交易时段后)订立买卖协议A，卖方有条件同意出售而买方A有条件同意购入待售股份A(92267股VAX股份，即VAX全部已发行股本约3.8%)，总代价为840万港元。</p><p>卖方与买方B(梁德辉)于2024年12月30日(联交所交易时段后)订立买卖协议B，卖方有条件同意出售而买方B有条件同意购入待售股份B(73118股VAX股份，即VAX全部已发行股本约3.0%)，总代价为660万港元。</p><p>董事局相信该等出售事项将使集团能够套现于VAX集团的投资。再者，考虑到(i)总代价相当于独立估值师所估算的16.54万股VAX股份的公平值1450万港元;(ii)卖方于2021年4月30日订立相关认购协议时16.54万股VAX股份的原认购价1290万港元;及(iii)预期来自该等出售事项的收益，该等出售事项诚属以有利价格套现16.54万股VAX股份的价值并将资源更好地分配至集团现有业务发展的大好良机。经考虑上述，董事相信该等出售事项的条款(包括总代价)乃按一般商业条款订立，诚属公平合理，且该等出售事项符合公司及股东的整体利益。</p></body></html>","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>易通讯集团(08031)附属拟1500万港元出售约6.8%的VAX全部已发行股本</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n易通讯集团(08031)附属拟1500万港元出售约6.8%的VAX全部已发行股本\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-30 23:03 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1231336.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，易通讯集团(08031)发布公告，卖方(ETS Investments Limited，公司的间接全资附属公司)与买方A(精益集团有限公司)于2024年12月30日(联交所交易时段后)订立买卖协议A，卖方有条件同意出售而买方A有条件同意购入待售股份A(92267股VAX股份，即VAX全部已发行股本约3.8%)，总代价为840万港元。卖方与买方B(梁德辉)于2024年12月30日(...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1231336.html\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1150","symbol_name":"人力资源与就业服务","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1231336.html","article_id":"2495526651","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2495526651","pubTimestamp":1735571020,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"卖方与买方B(梁德辉)于2024年12月30日订立买卖协议B，卖方有条件同意出售而买方B有条件同意购入待售股份B，总代价为660万港元。董事局相信该等出售事项将使集团能够套现于VAX集团的投资。经考虑上述，董事相信该等出售事项的条款乃按一般商业条款订立，诚属公平合理，且该等出售事项符合公司及股东的整体利益。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1150":"人力资源与就业服务","08031":"易通讯集团","BK1165":"办公服务与用品"},"translate_title":"The subsidiary of E-Communications Group (08031) plans to sell approximately 6.8% of the entire issued share capital of VAX for HK $15 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"08031":1},"content_text":"智通财经APP讯，易通讯集团(08031)发布公告，卖方(ETS Investments Limited，公司的间接全资附属公司)与买方A(精益集团有限公司)于2024年12月30日(联交所交易时段后)订立买卖协议A，卖方有条件同意出售而买方A有条件同意购入待售股份A(92267股VAX股份，即VAX全部已发行股本约3.8%)，总代价为840万港元。卖方与买方B(梁德辉)于2024年12月30日(联交所交易时段后)订立买卖协议B，卖方有条件同意出售而买方B有条件同意购入待售股份B(73118股VAX股份，即VAX全部已发行股本约3.0%)，总代价为660万港元。董事局相信该等出售事项将使集团能够套现于VAX集团的投资。再者，考虑到(i)总代价相当于独立估值师所估算的16.54万股VAX股份的公平值1450万港元;(ii)卖方于2021年4月30日订立相关认购协议时16.54万股VAX股份的原认购价1290万港元;及(iii)预期来自该等出售事项的收益，该等出售事项诚属以有利价格套现16.54万股VAX股份的价值并将资源更好地分配至集团现有业务发展的大好良机。经考虑上述，董事相信该等出售事项的条款(包括总代价)乃按一般商业条款订立，诚属公平合理，且该等出售事项符合公司及股东的整体利益。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}